Health Condition 1: H041- Other disorders of lacrimal gland
Conditions
Interventions
Intervention1: Individualised Homoeopathic medicines : Homoeopathic drugs as detailed in the standard Homoeopathic Materia Medica and in the Homoeopathic Pharmacopoeia (India/US) will be used in the
Sponsors
Central Council for Research in Homoeopathy
Eligibility
Inclusion criteria
Inclusion criteria: Male or female patient aged 18 years or above. Presenting with at least two of dry eye related symptoms, including itching, dryness, foreign body sensation, burning, blurred vision, photophobia, and soreness or pain etc in at least one of the eye. Diagnosis of mild to moderate dry eye syndrome with or without Sj grens syndrome. Best corrected visual acuity 6/18. Following results in at least one of the eye Ocular Surface Disease Index OSDI test symptoms between 12 and 33 Tear film break up time less than or equal to 10 seconds in atleast one of the eye. Willing to follow the study schedule and provide written informed consent
Exclusion criteria
Exclusion criteria: 1 Complaints of ocular comorbidity including non-dry eye ocular inflammation, severe blepharitis, glaucoma, contact lens allergy or any condition known to have effect on the study outcome. 2 History of any Trauma or eye surgery during last 3 months 3 Presenting with any uncontrolled systemic disease or significant illness and other autoimmune or connective tissue disorders such as rheumatoid arthritis and lupus, and thyroid disease. 4 Current use of topical ophthalmic medications that could affect dry eye syndrome and not willing to stop. 5 Pregnant &/or lactating female or considering a pregnancy.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change in Ocular Surface Disease Index OSDI score Change in intensity of symptoms of dry eye disease on VAS self-assessment of ocular discomfort reported by participants Timepoint: Baseline, monthly for 06 months | — |
Secondary
| Measure | Time frame |
|---|---|
| -Change in tear film break-up time -Change in Tear osmolarityTimepoint: Baseline and end of treatment at 06 months | — |
Countries
India
Contacts
Public ContactDr Subhash Kaushik
Central Council for Research in Homoeopathy
Outcome results
None listed